Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ingredion (INGR) EBT (2016 - 2026)

Ingredion filings provide 17 years of EBT readings, the most recent being $207.0 million for Q4 2025.

  • On a quarterly basis, EBT rose 36.18% to $207.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $974.0 million, a 4.62% increase, with the full-year FY2025 number at $974.0 million, up 4.62% from a year prior.
  • EBT hit $207.0 million in Q4 2025 for Ingredion, down from $241.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $276.0 million in Q1 2024 to a low of -$188.0 million in Q1 2021.
  • Median EBT over the past 5 years was $200.5 million (2021), compared with a mean of $183.0 million.
  • Biggest five-year swings in EBT: plummeted 238.24% in 2021 and later skyrocketed 199.47% in 2022.
  • Ingredion's EBT stood at $78.0 million in 2021, then skyrocketed by 58.97% to $124.0 million in 2022, then soared by 41.94% to $176.0 million in 2023, then dropped by 13.64% to $152.0 million in 2024, then soared by 36.18% to $207.0 million in 2025.
  • The last three reported values for EBT were $207.0 million (Q4 2025), $241.0 million (Q3 2025), and $259.0 million (Q2 2025) per Business Quant data.